By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health wants to address what it sees as a lack of researchers who are cross-trained in pharmacogenomics and a range of life sciences disciplines by funding grants to train researchers in this newly expanding area.

NIH has set aside $1.5 million to support awards in 2012 that will be used to train early-stage scientists who will go on to find ways to apply pharmacogenomics knowledge and integrate it into personalized medicine practice.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.